Key result
Isolated epicardial LV lead implant using minithoracotomy after failed transvenous attempt yielded a 61.8% clinical response rate, with an 11.9% 1-year mortality and 17.5% complication rate.
Cohort (n=42)
Isolated epicardial LV lead implantation via minithoracotomy is a viable and relatively safe alternative for patients with failed transvenous CRT lead placement, yielding a reasonable clinical response rate.
Answers are grounded in this paper and cite their sources.
May support epicardial LV lead via minithoracotomy after failed transvenous CRT; leaves open need for randomized confirmation.
BACKGROUND: Transvenous left ventricular (LV) lead placement for cardiac resynchronization therapy is unsuccessful in 5-10% of reported cases. These patients may benefit from isolated surgical placement of an epicardial LV lead via minithoracotomy approach. AIM: To evaluate the success of this approach at long-term follow-up. METHODS: Retrospective evaluation of all consecutive patients undergoing isolated epicardial LV lead placement after failed transvenous attempt over a 6-year period. Data collected on baseline parameters, procedural details, and outcome at follow-up (hospital stay, complications, mortality, and clinical response). RESULTS: Forty-two patients underwent epicardial lead implant. Five died within 1 year (11.9%): two (4.8%) died within 30-days post op (one from intraoperative hemorrhage, the other from multiple organ failure); 39 (95.1%) were admitted to the high dependency unit and transferred to the ward <24 hours. Median hospital stay was 3.4 ± 1.9 days. The overall complication rate was 17.5% (n = 7): 15.0% (n = 6) short term and 2.5% (n = 1) long term; these included three (7.5%) LV noncapture events all treated with reprogramming. There were two (5.0%) wound infections requiring oral antibiotics and two (5.0%) device infections requiring intravenous antibiotics (one had device resiting, the other developed septic shock requiring intensive care admission). Assessment of clinical response was possible in 34 (81.0%) at follow-up: 21 (61.8%) were responders and 13 (28.2%) nonresponders with no significant differences between these groups; no clinical predictors of response were identified. CONCLUSION: Isolated epicardial LV lead implant using minithoracotomy is relatively safe and effective at successful LV pacing. Response rate and postoperative recovery at long-term follow-up are reasonable in these high-risk patients.
No takes yet. Share an insight, caveat, or question.
McAloon et al. (2016) conducted a cohort in Failed transvenous left ventricular lead placement for cardiac resynchronization therapy (n=42). Isolated epicardial LV lead implant using a minithoracotomy approach was evaluated on Success of the approach at long-term follow-up (hospital stay, complications, mortality, and clinical response). Isolated epicardial LV lead implant using minithoracotomy after failed transvenous attempt yielded a 61.8% clinical response rate, with an 11.9% 1-year mortality and 17.5% complication rate.
Synapse has enriched 10 related papers. Consider them for comparative context: